Interspecies scaling: A comparative study for the prediction of clearance and volume using two or more than two species
The DOI matches its Crossref record; 17 of the 20 references it cites were found in a registry or an index.
Abstract
The prediction of pharmacokinetic parameters in humans from data obtained in lower animals can be of considerable importance in the process of drug development. Successful extrapolation will facilitate drug dosing transitions from animals to man and accelerate the drug testing process. Existing literature indicates that for the prediction of pharmacokinetic parameters, data from at least three animal species are used. Some investigators have used only two species to predict clearance and volume in humans. The objective of this paper is to investigate and try to determine if a two species scale-up model is as reliable as a three or more species model. Twelve compounds were chosen randomly from literature and clearance and volume of distribution were scaled-up from two species and compared to predictions obtained from more than two species. The findings in this study indicate that: (1) three or more species are needed for a reliable prediction of clearance; and (2) volume of distribution of a compound is predicted equally well using data from two species or more.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the study of Mahmood and Balian [108], the average exponents using the simple AS for the prediction of Vd are 0.89 and 0.90 in case of 3 and 2 species, respectively.”
From Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling (2019) · cites this paper as [108]
Citations
Cites
Some suggestions for measuring predictive performance
Sheiner, L. B., & Beal, S. L. (1981) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01060893 · Cited by 1,617
Interspecies Comparison of In Vivo Caffeine Pharmacokinetics in Man, Monkey, Rabbit, Rat and Mouse
Bonati, M., Latini, R., Tognoni, G., Young, J. F., & Garattini, S. (1984) · Drug Metabolism Reviews · doi:10.3109/03602538409029964 · Cited by 169
First‐Time‐in‐Human Dose Selection: Allometric Thoughts and Perspectives
Boxenbaum, H., & DiLea, C. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04011.x · Cited by 161
(1992) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049209043866 · Cited by 118
Sawada, Y., Hanano, M., Sugiyama, Y., & Iga, T. (1984) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061720 · Cited by 117
Pharmacokinetic Scale-up: Accurate Prediction of Human Pharmacokinetic Profiles from Animal Data
Mordenti, J. J. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600741017 · Cited by 87
Comparative pharmacokinetics of benzodiazepines in dog and man
Boxenbaum, H. G. (1982) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01065172 · Cited by 84
Ciba Foundation Colloquia on Aging
Montagu, A. (1964) · American Journal of Psychiatry · doi:10.1176/ajp.120.7.727-a · Cited by 60
Interspecies Correlation of the Pharmacokinetics of Erythromycin, Oleandomycin, and Tylosin
Duthu, G. S. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740907 · Cited by 56
Sangalli, L., Bortolotti, A., Jiritano, L., & Bonati, M. (1988) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07045-x · Cited by 55
Research works printed but not linked: 2
- McGovern, 1988, Drug. Metab. Dispos., 16, 18
- Sangalli, 1988, Drug. Metab. Dispos., 16, 749
Cited by
The Prediction of Human Pharmacokinetic Parameters from Preclinical and in Vitro Metabolism Data
Obach, R. S., Baxter, J. G., Liston, T. E., Silber, B. M., Jones, B. C., Macintyre, F., Rance, D. J., & Wastall, P. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36999-x · Cited by 987
Property-Based Design: Optimization of Drug Absorption and Pharmacokinetics
van de Waterbeemd, H., Smith, D. A., Beaumont, K., & Walker, D. K. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000407e · Cited by 599
Caldwell, G. W., Masucci, J. A., Yan, Z., & Hageman, W. (2004) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190588 · Cited by 148
“Most of these studies recommend that the data from two or more animal species be used for these predictions (32).”
BackgroundInterspecies Scaling of Therapeutic Monoclonal Antibodies: Initial Look
Ling, J., Zhou, H., Jiao, Q., & Davis, H. M. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009337134 · Cited by 144
“Although successful prediction using a single species or a fixed exponent has been published,(30,51,55,66) the general consensus has been that 3 or 4 species are required for human CL prediction.(14,15,28,32) It has been previously demonstrated that CL for 3 mAbs (pertuzumab, bevacizumab, and trastuzumab) could be acc…”
BackgroundMethodThe Pharmacokinetic Principles Behind Scaling from Preclinical Results to Phase I Protocols
Mahmood, I., & Balian, J. D. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936010-00001 · Cited by 112
Self-citation
Metadata
- Authors
- Mahmood, I., & Balian, J. D.
- Affiliations
- United States Food and Drug Administration (US)
- Corresponding author
- Mahmood, Iftekhar
- ORCID
- Mahmood, Iftekhar
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 1996-07
- Volume
- 59
- Issue
- 7
- Pages
- 579-585
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2063603694
- Cited by
- 72
- References
- 20
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2022: 1 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 1 · 2015: 3 · 2013: 4 · 2012: 3
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Life Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- interspecies scaling, clearance, volume of distribution, animal-to-human extrapolation, drug development
- MeSH terms
- Animals, Haplorhini, Dogs, Guinea Pigs, Humans, Metabolic Clearance Rate, Models, Biological, Pharmacokinetics, Rabbits, Species Specificity, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interspecies scaling: A comparative study for the prediction of clearance and volume using two or more than two species. https://app.cochat.ai/papers/10.1016/0024-3205(96)00339-6
- The paper
- Mahmood, I., & Balian, J. D. (1996). Interspecies scaling: A comparative study for the prediction of clearance and volume using two or more than two species. Life Sciences. https://doi.org/10.1016/0024-3205(96)00339-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.